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Abstract: The benzylisoquinoline alkaloids (BIAs) are an important 
group of secondary metabolites from higher plants and have been 
reported to show significant biological activities. The production of BIAs 
through synthetic biology approaches provides a higher-yielding 
strategy than traditional synthetic methods or isolation from plant 
material. However, the reconstruction of BIA pathways in 
microorganisms by combining heterologous enzymes can also give 
access to BIAs through cascade reactions. Most importantly, non-
natural BIAs can be generated through such artificial pathways. In the 
current study, we describe the use of tyrosinases and decarboxylases 
and combine these with a transaminase enzyme and norcoclaurine 
synthase for the efficient synthesis of several BIAs, including six non-
natural alkaloids, in cascades from L-tyrosine and analogues. 
Benzylisoquinoline alkaloids (BIAs) are a structurally 
diverse group of natural products showing potent 
pharmaceutical significance. Their well-studied therapeutic 
fields cover antibacterials, anti-inflammatories and anti-virals, 
and they are also used as a coronary vasodilator and 
microtubule disrupter.[1,2] Further applications are being 
discovered, including the known antimicrobial berberine, which 
has been reported to downregulate β-catenin signaling in colon 
tumor cells, and have cholesterollowering effects.[3,4] 
In higher plants, natural BIAs share a common central 
precursor (S)-norcoclaurine (S)-1, which is synthesized from 
the condensation of dopamine 2 and 4-
hydroxyphenylacetaldehyde (4-HPAA 3) via a Pictet-Spengler 
reaction catalyzed by norcoclaurine synthase (NCS).[5] 
Dopamine 2 is generated by the ortho-hydroxylation and 
decarboxylation of L-tyrosine 4 by a tyrosine hydroxylase and 
DOPA decarboxylase (DODC), respectively. In a parallel 
pathway, 4-HPAA 3 is formed from the deamination of L-
tyrosine 4 to 4-hydroxyphenylpyruvate by a tyrosine 
aminotransferase and is then decarboxylated to 4-HPAA 3 by a 
4-hydroxyphenylpyruvate decarboxylase.[5,6] Through the 
Pictet-Spenglerase reaction, dopamine 2 becomes the origin of 
the isoquinoline moiety, and 4-HPAA 3 is incorporated into the 
benzyl moiety, resulting in the benzylisoquinoline nucleus of 
(S)-1. Recent reports using recombinant NCSs from Thalictrum 
flavum (TfNCS), Coptis japonica (CjNCS) and Papaver 
bracteatum (PbNCS) have highlighted their versatility in BIA 
and tetrahydroisoquinoline (THIA) synthesis using a range of 
aldehydes and several ketones.[7-11] X-ray crystallographic and 
modelling studies have also enhanced a mechanistic 
understanding.[12-14] In addition, their incorporation into 
enzymatic and chemoenzymatic cascades to give THIAs in 
high yields and stereoselectivities has demonstrated their 
potential in sustainable synthesis.[15-18] 
To date, BIAs are mainly obtained by plant extraction. 
However, the yield is normally not high due to the low 
accumulation levels in native plant cells along with other 
complex metabolites and challenging isolation procedures.[19] 
The structural complexity of many BIAs also means that 
chemical synthesis via multistep procedures are not viable on 
an industrial scale.[20-22] Synthetic biology has provided a new 
approach to BIA biosynthesis in recent years. Indeed, the 
reconstruction of BIA pathways in microorganisms, such as E. 
coli or S. cerevisiae, with bacterial or plant enzymes has 
enabled the production of BIAs via fermentation in vivo 
(Scheme 1A), although racemic NCS products were noted in a 
number of cases.[23-29] Additionally, such heterologous 
pathways can also be achieved by combining enzymes into 
cascade reactions in vitro (Scheme 1B). This highly valuable 
strategy enables the introduction of greater structural diversity 
to produce novel alkaloids, as alternative substrates or enzyme 
steps can be incorporated that are not compatible with natural 
in vivo pathways. 
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Scheme 1. (A): Representation of previous in vivo approaches to alkaloid natural 
products. (B): Representation of in vitro approaches to novel alkaloids in this 
work. 
In this study, we describe de novo BIA cascades to synthesize 
non-natural BIAs using the amino acid L-tyrosine 4 and analogues. 
To achieve this, tyrosinases, and decarboxylases were identified 
and incorporated with transaminase (TAm) and NCS enzymes in 


















































The first step in the conversion of tyrosine or analogues to 
meta-hydroxylated phenethylamines, required for the Pictet-
Spenglerase reaction, is an ortho-hydroxylation. Several enzymes 
have been reported to do this, mammalian tyrosine hydroxylases 
(TyrHs), tyrosinases (TYRs) and recently a cytochrome P450 
oxidase.[23,26,30] Since mammalian TyrHs require a 
tetrahydrobiopterin cofactor that E. coli cannot produce, it was 
decided to investigate the use of TYRs. Ralstonia solanacearum 
tyrosinase (Gene: RSc0337) has previously been reported to have 
high monophenolase activity,[31] and has been incorporated into the 
fermentative production of racemic NCS products.[24,26] Based on 
sequence homology to the reported RsTYR, Cu-dependent TYRs 
from Ralstonia solanacearum (Rs, Gene: RSc1501, 25% identity 
to RSc0337), Bacillus megaterium (Bm), Rhizobium meliloti (Rm), 
and Candidatus nitrosopumilus (Cn) were selected and expressed 
in E. coli (18-41% sequence identity to RsTYR (RSc0337); SI Fig. 
S1 for sequence alignments). In addition, two Cu/co-factor protein 
(CoF) TYRs from Streptomyces avermitilis (Sav) and 
Streptomyces antibioticus (San) and one para-hydroxybenzoate 
hydroxylase (PHBH) from Pseudomonas aeruginosa (Pa) were 
also chosen. Enzymes were readily expressed and used as crude 
cell lysates with L-Tyr 4 (2.5 mM) to give L-DOPA 5, and tyramine 
6 (2.5 mM) to give dopamine 2 using optimized conditions of pH 
5.5 and 25 oC with a 500 μL reaction (Figure 1). The addition of 
sodium ascorbate 7 was found to reduce problems with quinone 
formation so was used in TYR assays and cascades. 
Figure 1. Reactions A and B with the TYRs and PaPHPB, 0.4 mg/mL cell lysate 
(containing 15-40% of the recombinant protein), HEPES (50 mM), 7 (4 equiv.), 
CuSO4 (0.4 equiv) (or FAD and NADPH with PHBH), 4 or 6 (2.5 mM), at pH 5.5, 
25 oC, 250 rpm, 8 h, and a total reaction volume of 500 μL. Yields were 
determined by HPLC analysis at 280 nm of the products formed (5 and 2); (  ) L-

























Both the new RsTYR and CnTYR gave 5 and 2 in high yield 
(>95%), highlighting them as useful tyrosinases in biocatalytic 
reactions and one CnTYRwas selected for further study. Three 
enzymes, PaPHBH, SavTYR and SanTYR gave 5 and 2 only in low 
yields (< 20%). Enzymes BmTYR and RmTYR showed a 
preference towards 4, giving 5 in 30%-75% yield and 2 in lower 
yields (15%-45%). Using purified CnTYR the apparent Km,app and 
kcat.app towards L-tyrosine 4 were 1.78 mM and 31.6 s-1 
(kcat,app/Km,app 1.78 x 104 s-1 M-1) and tyramine 6 3.43 mM and 
55.2 s-1 (kcat,app/Km,app 1.61 x 104 s-1 M-1), respectively: although 
CnTYR showed greater affinity towards 4, the kcat,app was higher 
with 6. Sequence identity to a related TYR from Cn koreensis[32]  
 
is 54%, where the Km and kcat towards 4 were 9.2 mM and 4.3 
s-1 (kcat/Km 4.7 x 104 s-1 M-1): a higher apparent monophenolase 
activity with the CnTYR identified here may be due to the 
addition of 7. 
The decarboxylation of L-DOPA 5 to give dopamine 2 has 
been reported in BIA pathways by Psuedomonas putida DOPA 
decarboxylase (PpDODC) where it was required to have higher 
activity towards 5 rather than 4 to avoid side product formation. 
[24,26] PpDODC was selected for use here together with new 
tyrosine decarboxylases (TyrDC) from Lactobacillus brevis (Lb) 
and Enterococcus faecalis (Ef).[33,34] Good substrate tolerance 
was also sought with non-natural substrates. Sequence 
identities for both EfTyrDC and LbTyrDC to PpDODC are 21% 
(SI Fig. S2 for sequence alignments). Two of the enzymes, 
PpDODC, LbTyrDC showed low levels of decarboxylation 
(<10%) (Figure 2). EfTyrDC gave the best performance towards 
both 4 and 5 (at 2.5 mM) (> 90% yield by HPLC) at optimised 
conditions compatible with the TYR of pH 5.5 and 25 oC. The 
apparent Km and kcat, of EfTyrDC with 4 were 1.58 mM and 39.0 
s-1 (kcat,app/Km,app 2.47 x 104 s-1 M-1) and with 5 were 2.31 mM 
and 60.2 s-1 (kcat,app/Km,app 2.61 x 104 s-1 M-1), respectively. Due 
to the promising activities displayed by the new enzymes 
CnTYR and EfTyrDC, they were selected for use in in vitro BIA 

























Figure 2. Reactions C and D with the DCs, 0.4 mg/mL cell lysate (20% of the 
recombinant protein), 4 or 5 (2.5 mM), PLP, at pH 5.5, 25 oC, 250 rpm, 8 h. 
Reaction volume: 500 μL.Convertion yields were determined by HPLC analysis 
at 280 nm of the products 6 and 2. (   ) Tyramine 6 yield reaction C; (   ) 
Dopamine 2 yield reaction D. 
The substrate tolerance of CnTYR towards analogues of 4, 
metaL-tyrosine 8, 3-F-L-tyrosine 9, 3-Cl-L-tyrosine 10 and 3-I-
Ltyrosine 11 was investigated. No conversions were observed 
for the halogenated tyrosines 10 and 11, indeed 11 has been 
reported to be a mixed type inhibitor, which is competitive and 
non-competitive for some TYRs.[35] 2-Chlorophenol has also 





















































Substrate/ R group Product Conversion yields  
L-Tyr 4 tyramine 6 quantitative 

















































Interestingly, 3-F-L-tyrosine 9 (2.5 mM) was readily 
accepted, with an 80% conversion yield (48 h) to give the 
corresponding F-DOPA analogue 12. Indeed, some previous 
work has indicated that 9 can be accepted by a tyrosinase.[37] 
The substrate tolerance of EfTyrDC was also investigated using 
meta-L-tyrosine 8, and the halogenated tyrosine analogues 9-
11, 13 (at 2.5 mM, Table 1). Decarboxylated products were 
readily formed in all cases giving 14–18 in 90-100% conversion 
yields, and 7 was added to avoid substrate or product oxidation. 
Overall the reactions highlighted EfTyrDC as an extremely 
efficient and versatile decarboxylase, providing a novel route to 
14, 15, 17 and 18.[38] 
Table 1. Decarboxylation of tyrosine analogues by EfTyrDC 
The construction of multi-step one-pot in vitro enzyme 
cascades were then established using CnTYR, EfTyrDC, together 
with a versatile transaminase from Chromobacterium violaceum 
(CvTAm) and wild-type 29TfNCS that have been used in some 
enzyme cascades and demonstrated good substrate tolerances. 
[16,17,39,40] Initially, three cascades were developed using L-tyrosine 
4 (at 2.5 mM, Table 2, entries 1-3). First the one-pot reaction was 
developed using CnTYR, EfTyrDC to produce dopamine 2, 
followed by the addition of phenylacetaldehyde 19 and TfNCS. It 
was necessary to ensure that the TYR and DC reactions were not 
performed in phosphate buffer, due to the reported competing 
chemical Pictet-Spengler reaction.[41] In addition, it was noted that 
while TfNCS did not accept L-DOPA 5, due to its high reactivity  
Reaction conditions: EfTyrDC 0.4 mg/mL cell lysate (22% of the recombinant 
protein), substrate (2.5 mM), PLP, 7 (10 mM), pH 5.5, 25 oC, 250 rpm, 8 h, 
reaction volume: 500 μL. Conversion yields were determined by HPLC analysis 
at 280 nm, based on substrate consumption. *Reaction required 7 d. 
 
some background chemical Pictet-Spengler reaction was also 
noted in HEPES buffer requiring the full conversion of 5 into 2 prior 
to the addition of 19. The TYR and DC reactions were optimized in 
a one-pot cascade at 30 oC and pH 5.5 for 12 h, with subsequent 
adjustment of the reaction pH to 7.5, and addition of the aldehyde 
and TfNCS for a 6 h reaction at 37 oC. This gave the non-natural 
BIA (S)-20 in 66% isolated yield (99% yield by analytical HPLC) 
and >97% e.e. via a three-enzyme cascade. The lower isolated 
yields reflected the challenges of purifying such alkaloids that 
has been noted in the literature.[42] The four-enzyme cascade 
to the natural BIA (S)-norlaudanosoline (S)-21 was then 
established combining CnTYR, EfTyrDC, CvTAm and TfNCS, 
utilizing only 4 as the starting material to extend the previously 
reported triangular cascade.[16] The dopamine 2 formed was 
converted to 2-(3,4-dihydroxyphenyl)-acetaldehyde 22 by 
CvTAm and addition of TfNCS gave (S)-21 in 53% isolated yield 
(98% yield by analytical HPLC) and >97% e.e. Furthermore, to 
demonstrate the general applicability of this approach the 
reaction was scaled to 1 g giving (S)-21 in 43% isolated yield 
(85% HPLC yield). A different one-pot four-enzyme cascade 
was also established towards (S)-norcoclaurine (S)-1 
combining CnTYR, EfTyrDC, CvTAm and TfNCS, but using a 
different order of addition, exploiting the ability of the TYR to 
hydroxylate tyramine 6 (entry 3). Firstly, 4 was decarboxylated 
to 6 by EfTyrDC, then hydroxylated to 2 by CnTYR, while 6 was 
also converted to 4- HPAA 3 by adding CvTAm. Finally, 2 was 
reacted with 3 by the addition of TfNCS, giving (S)-1 in 62% 
isolated yield (85% yield by HPLC) and >97% e.e. 
One-pot cascades using meta-L-tyrosine 8 (10 mM) were 
then established which is an efficient method of generating 14 
(entries 4-6). The first, was a two-step reaction using EfTyrDC 
to convert 8 into 14, which was then reacted with 19, yielding 
(S)-23 in 25% isolated yield (82% yield by HPLC) and >97% 
e.e. Using an analogous approach and 2-
bromophenylacetaldehyde 24, (S)-25 was formed in 28% 
isolated yield (45% yield by HPLC) and 75% e.e., presumably 
reflecting the effect of introducing a bulkier aryl group at C-1. 
Using 8 (entry 6) a three-enzyme cascade was constructed with 
EfTyrDC to generate 14, which was converted into 3-
hydroxyphenylacetaldehyde 26. A subsequent reaction 
between 14 and 26 by the addition of TfNCS gave (S)-27 in 
32% isolated yield (78% yield by HPLC) and 95% e.e. Again, 
this reaction was demonstrated on a larger scale using 
approximately 0.5 g of 8 to give (S)-27 in 39% isolated yield 
(72% by HPLC) which was comparable to the smaller scale 
reaction. Using an alternative starting material to demonstrate 
the versatility of the strategy 9 (15 mM), which has higher water 
solubility than 4, was hydroxylated using CnTYR to give 12, 
then decarboxylated with EfTyrDC to give amine 28 and 
subsequently reacted with 19 via the addition of TfNCS to give 
the novel BIA (S)-29 in 23% overall isolated yield (35% yield by 
HPLC) and 90% e.e. (entry 7). Finally, to show that the 
cascades can be applied to non-amino acids, (rac)-octopamine 
30 (40 mM) was hydroxylated using CnTYR to give 
noradrenaline 31 and then reacted with TfNCS and 19 to give 
(1S,4RS)-32 in 47% isolated yield (65% yield by HPLC) and a 
ratio of 5:3 (1S,4R):(1S,4S) (entry 8). The use of other NCS 
variants did not significantly affect the isomeric ratio of 32 (see 




[a] Yields were determined by HPLC analysis at 280 nm against products standards. [b] For preparative-scale reactions products were purified by 
preparative HPLC or by using an extraction method (see the Supporting Information). [c] ee values were determined by chiral HPLC (>97% 
indicates that no minor isomer was detected and reflects the limits of detection). Reaction conditions: Details are provided in the Supporting 
Information and are specific to each cascade. As an example, for entry 1, a 50 mL reaction consisting of HEPES (50 mm), CnTYR and EfTyrDC 
(10% lysate (v/v)) and 4 (2.5 mm) in 10% DMSO (v/v), at pH 5.5, 25oC, 7 (4 equiv), PLP, CuSO4, was run for 8 h at 250 rpm. The pH was then 
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In conclusion, two enzymes, tyrosinase CnTYR and 
tyrosine decarboxylase EfTyrDC, were cloned and used with a 
range of substrates to highlight their use with nonnatural 
analogues. When combined together in different combinations 
with 4, 8, 9, and 30 and the additional enzymes CvTAm and 
TfNCS, artificial cascades were successfully constructed, 
giving BIAs in 23–66% yields of isolated product (35–99% 
yields by HPLC) and high stereoselectivity over up to 4 enzyme 
steps. Moreover, selected reactions were scaled up 
successfully to 1 g. Overall, this work highlights the versatility 
of the “mix and match” strategy with enzymes in vitro to 
generate two natural and six non-natural BIAs. Interestingly, in 
parallel with this work, the synthesis of noscapine and 
halogenated BIAs in yeast has been reported using a reported 
TyrH and DODC, together with other downstream biosynthetic 
enzymes in vivo.[43] While some halogenated BIAs were 
detected, it was unclear how much was produced or what the 
stereoselectivity was. Here, the one-pot in vitro cascades 
demonstrate an extremely powerful strategy for introducing 
molecular diversity using sustainable catalysts. 
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